From June 2023, all our podcasts will move to https://jnnpbmj.podbean.com.
You can continue with your subscription on your favourite podcast App.


JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. 
* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

JNNP podcast

Mark Goh and Shu-Ling Chong, Duke-NUS Medical School and KK Women's and Children's Hospital, Singapore joins editor Colin Mahoney to discuss their systematic review and meta-analysis spanning 6000 articles dealing with neurocognitive outcomes following traumatic brain injury (TBI) in children. They highlight how dose of TBI impacts executive function and memory with potentially long term impacts. https://jnnp.bmj.com/content/92/8/847

The impact of traumatic brain injury on neurocognitive outcomes in children

A/Prof Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh  joins editor Colin Mahoney to discuss  the first comprehensive guidelines developed to assist speech and language professionals in the management of functional communication, voice, swallow and cough disorders. As part of a global team they have developed a set of clinically focused guidelines in the recognition and management of theses disorders and discuss the highlights on the Podcast. https://jnnp.bmj.com/content/92/10/1112

Guidelines for the management of functional speech and communication disorders

11. Thiền Ngay Bây Giờ  -  Thiền Sư S.N Goenka

Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). 
Prof Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies.
Related paper: https://jnnp.bmj.com/content/92/12/1319

Alemtuzumab's impact on functional and structural integrity of the visual system in MS

In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.
Related article: https://jnnp.bmj.com/content/92/12/1325

CGRP in migraine: current therapeutics, future implications and potential off-target effects

Why the 1940s was such a terrible time for Ukraine is the subject of Class 16.

Timothy Snyder is the Richard C. Levin Professor of History at Yale University and a permanent fellow at the Institute for Human Sciences in Vienna. He speaks five and reads ten European languages.

Ukraine must have existed as a society and polity on 23 February 2022, else Ukrainians would not have collectively resisted Russian invasion the next day.  What does it mean for a nation to exist?  Is this a matter of structures, actions, or both?  Why has the existence of Ukraine occasioned such controversy?  In what ways are Polish, Russian, and Jewish self-understanding dependent upon experiences in Ukraine?  Just how and when did a modern Ukrainian nation emerge?  For that matter, how does any modern nation emerge?  Why some and not others?  Can nations be chosen, and can choices be decisive?  If so, whose, and how?  Ukraine was the country most touched by Soviet and Nazi terror: what can we learn about those systems, then, from Ukraine?  Is the post-colonial, multilingual Ukrainian nation a holdover from the past, or does it hold some promise for the future?

16: Colonization, Extermination, Ethnic Cleansing

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. David Cibula to discuss the 2023 ESGO-ESTRO-ESP Guidelines for Cervical Cancer. Dr. Cibula is the Chair of the Department of Obstetrics and Gynecology at the General Faculty Hospital in Prague, Professor at the First Medical Faculty of the Charles University, Chair of the Central and Eastern European Gynaecologic Oncology Group (CEEGOG), member of the Strategic group of the ENGOT (European Network for Gynaecological Oncological Trial Groups) as well as a Former ESGO president.

 Highlights:

- Multidisciplinary clinical practice guidelines developed jointly by ESGO/ESTRO/ESP in the field of gynaecological oncology, radiation oncology and pathology.

- Guidelines cover the management of all stages of cervical cancer, including separate sections dedicated to pathology reporting and management in pregnancy.

- The guidelines include recommendations, algorithms, and summaries of recent evidence published as supplements.

ESGO-ESTRO-ESP Guidelines for Cervical Cancer 2023 with David Cibula

In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https://jnnp.bmj.com/content/94/3/201

(1) Warren Alpert Medical School, Brown University, Rhode Island, USA
(2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy 

Please subscribe to the show on Apple Podcasts (https://podcasts.apple.com/gb/podcast/jnnp-podcast/id426391174), Spotify (https://open.spotify.com/show/3VHlgiFD3LRw395wBB167T) or find it on your platform of choice. Your feedback and reviews are very appreciated.

Follow JNNP on twitter: https://twitter.com/jnnp_bmj

MOGAD: Definition, diagnosis and treatment

Effortless English

Day of the Dead Vocab

IELTS Listening Recent Actual Test Vol1 - Test 4

50 Study Music - Studying Music & Concentration Music for School and University Exam Study, Brain Stimulation, Improve Memory and Concentration

Music for Studying

Deep Gamma Waves Meditation Soundscapes

The 2018 Environmental Performance Index (EPI) ranks 180 countries on 24 performance indicators across ten issue categories covering environmental health and ecosystem vitality. These metrics provide a gauge at a national scale of how close countries are to established environmental policy goals. The EPI thus offers a scorecard that highlights leaders and laggards in environmental performance, gives insight on best practices, and provides guidance for countries that aspire to be leaders in sustainability.

20th Anniversary of the Environmental Performance Index

Prof John O'Brien (University of Cambridge) and Dr Dominic Ffytche (Kings College London) join Dr Colin Mahoney (Podcast Editor)
Visual hallucinations have complex origins and can have significant impact on patients. The recent UK based SHAPED consortium has aimed to design a common framework for assessment, management and research in this area. John O'Brien and Dominic Ffytche discuss disorders which cause visual hallucinations as well as their pathobiology and management in this Podcast: https://jnnp.bmj.com/content/91/5/512

Visual hallucinations in neurological and ophthalmological disease

BMJ talk medicine

Related tracks